<![CDATA[Newer Oral Levodopa Formulations in Parkinson’s Disease]]>
Post Content: Source: Neurology Read More
<![CDATA[AskBio’s Late-Onset Pompe Disease Gene Therapy AB-1009 Cleared for Phase 1/2 Trial]]>
Post Content: Source: Neurology Read More
<![CDATA[Using Subcutaneous Self-Administered Lecanemab for Alzheimer Disease: Robert Przybelski, MD, MS]]>
Post Content: Source: Neurology Read More
<![CDATA[NLX-112 Shows Safety and Tolerability in Phase 2a Parkinson Trial, Supporting Further Development]]>
<![CDATA[Levacetylleucine Meets Primary and Secondary End Points in Phase 3 Ataxia-Telangiectasia Study]]>
What APA Is Doing for You: Update on Clozapine REMS
In November 2021, the Food and Drug Administration (FDA) instituted a new Clozapine Risk Evaluation and Mitigation Strategy (REMS) to…
Read More
